Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C14orf132 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-05 |
mRNA | BEX5 | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
mRNA | SYAP1 | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
mRNA | KIF3C | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-05 |
mRNA | USF2 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
mRNA | CDH24 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
mRNA | CTC-273B12.7 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
mRNA | GMFG | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-05 |
mRNA | RBBP4 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
mRNA | CASP2 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |